Barclays raised the firm’s price target on Molina Healthcare (MOH) to $164 from $144 and keeps an Underweight rating on the shares. The firm sees managed care stocks benefiting in 2026 from the prospects of margin expansion and rotation away from artificial intelligence-related stocks toward “de-rated underperformers.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Early notable gainers among liquid option names on December 31st
- Early notable gainers among liquid option names on December 30th
- Trump Trade: Trump strikes deals with nine drugmakers to cut prices
- President Trump says he’ll meet with insurance companies on price cuts
- Consumers left in limbo as ACA subsidies are not renewed, WSJ says